Analyst Ratings (USA)
American analyst sentiment remains cautiously optimistic but increasingly selective, with strong interest in utilities, power generation, defence, healthcare, and infrastructure-related sectors. Positive ratings and higher price targets reflect confidence in resilient earnings, energy demand, and long-term growth opportunities, while downgrades and target reductions across consumer discretionary, technology, and industrial stocks highlight concerns over valuations, slowing demand, and macroeconomic uncertainty.
Updates (418)
4D Molecular Therapeutics (FDMT) — Citigroup reiterated its Buy rating.
4D Molecular Therapeutics (FDMT) — HC Wainwright reiterated its Buy rating with a $36.00 price target.
Abbott Laboratories (ABT) — Robert W. Baird maintained its Outperform rating and raised its price target to $123.00 from $121.00.
Abbott Laboratories (ABT) — BTIG Research maintained its Buy rating and lowered its price target to $125.00 from $134.00.
Abbott Laboratories (ABT) — JPMorgan Chase & Co. maintained its Overweight rating and lowered its price target to $118.00 from $120.00.
Abbott Laboratories (ABT) — Royal Bank Of Canada maintained its Outperform rating and lowered its price target to $125.00 from $130.00.
Abbott Laboratories (ABT) — TD Cowen maintained its Buy rating and lowered its price target to $118.00 from $135.00.
Abbott Laboratories (ABT) — Wells Fargo & Company maintained its Overweight rating and raised its price target to $119.00 from $112.00.
Abercrombie & Fitch (ANF) — Wolfe Research initiated coverage with a Outperform rating and set a $181 price target.
Aegon (AEG) — JPMorgan downgraded the stock from Overweight to Neutral.
AeroVironment (AVAV) — Oppenheimer changed its rating from Buy to Outperform and set a $205.00 price target.
AEVEX (AVEX) — Jefferies Financial Group reiterated its Buy rating.
AEVEX (AVEX) — Oppenheimer initiated coverage with a Outperform rating and set a $21.00 price target.
AEVEX (AVEX) — Piper Sandler maintained its Neutral rating and lowered its price target to $13.00 from $20.00.
AEVEX (AVEX) — Royal Bank Of Canada maintained its Outperform rating and lowered its price target to $22.00 from $26.00.
AEVEX (AVEX) — UBS Group initiated coverage with a Outperform rating and set a $21.00 price target.
AGCO (AGCO) — Oppenheimer maintained its Outperform rating and lowered its price target to $123.00 from $127.00.
Agenus (AGEN) — Chardan Capital reiterated its Buy rating.
Alaska Air Group (ALK) — BMO Capital Markets reiterated its Outperform rating with a price target of $42.00, revised from $50.00.
Alaska Air Group (ALK) — Citigroup reiterated its Sell rating.
Alaska Air Group (ALK) — JPMorgan Chase & Co. maintained its Overweight rating and lowered its price target to $74.00 from $92.00.
Alaska Air Group (ALK) — Susquehanna maintained its Positive rating and lowered its price target to $43.00 from $50.00.
Alaska Air Group (ALK) — The Goldman Sachs Group reiterated its Buy rating with a $52.00 price target.
Albemarle (ALB) — Citigroup reiterated its Buy rating.
Alcoa (AA) — Argus downgraded the stock from Buy to Hold.
Align Technology (ALGN) — Mizuho maintained its Outperform rating and lowered its price target to $200.00 from $220.00.
Alignment Healthcare (ALHC) — The Goldman Sachs Group reiterated its Buy rating with a $12.00 price target.
Alliant Energy (LNT) — HSBC changed its rating from Buy to Hold and set a $69.50 price target.
Alphabet (GOOGL) — Citizens Jmp maintained its Market Outperform rating and lowered its price target to $450.00 from $515.00.
Ameren (AEE) — HSBC changed its rating from Hold to Buy and set a $119.10 price target.
Ameren (AEE) — TD Cowen initiated coverage with a Hold rating and set a $114.00 price target.
America Movil (AMX) — UBS Group reiterated its Buy rating with a $31.00 price target.
American Eagle Outfitters (AEO) — Wolfe Research initiated coverage with a Peer Perform rating.
American Electric Power (AEP) — HSBC initiated coverage with a Buy rating and set a $145.90 price target.
American Electric Power (AEP) — Jefferies Financial Group reiterated its Buy rating with a $145.00 price target.
Amneal Pharmaceuticals (AMRX) — JPMorgan Chase & Co. maintained its Overweight rating and raised its price target to $24.00 from $22.00.
Annaly Capital Management (NLY) — Barclays set a price target with a price target of $21.00, revised from $24.00.
Annaly Capital Management (NLY) — JPMorgan Chase & Co. maintained its Overweight rating and raised its price target to $19.50 from $19.00.
Annaly Capital Management (NLY) — Royal Bank Of Canada set a price target with a price target of $21.00, revised from $25.00.
Annaly Capital Management (NLY) — Wells Fargo & Company set a price target with a price target of $22.00, revised from $24.00.
AT&T (T) — Argus reiterated its Buy rating with a $30.00 price target.
AT&T (T) — Barclays maintained its Equal Weight rating and lowered its price target to $21.00 from $24.00.
AT&T (T) — JPMorgan Chase & Co. maintained its Overweight rating and lowered its price target to $31.00 from $33.00.
AT&T (T) — KeyCorp maintained its Overweight rating and lowered its price target to $33.00 from $36.00.
AT&T (T) — Morgan Stanley reiterated its Overweight rating with a price target of $25.00, revised from $28.00.
AT&T (T) — TD Cowen reiterated its Hold rating with a $33.00 price target.
Ategrity Specialty (ASIC) — Barclays maintained its Overweight rating and lowered its price target to $27.00 from $28.00.
Ategrity Specialty (ASIC) — Citigroup reiterated its Neutral rating.
Ategrity Specialty (ASIC) — Wells Fargo & Company maintained its Overweight rating and lowered its price target to $29.00 from $31.00.
Atlassian (TEAM) — Oppenheimer maintained its Outperform rating and raised its price target to $275.00 from $200.00.
Avidity Biosciences (RNA) — Roth Capital initiated coverage with a Buy rating and set a $15.00 price target.
BankUnited (BKU) — Royal Bank Of Canada maintained its Sector Perform rating and lowered its price target to $48.00 from $49.00.
Barings Bdc (BBDC) — Raymond James Financial set a price target of $9.00.
Beauty Health (SKIN) — Canaccord Genuity Group set a price target of $11.00.
Biodesix (BDSX) — HC Wainwright reiterated its Buy rating.
Biogen (BIIB) — Bank of America maintained its Neutral rating and raised its price target to $244.00 from $219.00.
Biohaven (BHVN) — Robert W. Baird set a price target of $48.00.
Blackstone (BX) — The Goldman Sachs Group reiterated its Neutral rating with a $128.00 price target.
Block (XYZ) — BMO Capital Markets upgraded the stock from Market Perform to Outperform and set a $101 price target.
Blue Owl Capital (OBDC) — Raymond James Financial set a price target of $11.00.
Booking (BKNG) — BTIG Research reiterated its Buy rating with a $250.00 price target.
Boot Barn (BOOT) — UBS Group reiterated its Buy rating with a $232.00 price target.
Broadcom (AVGO) — Tigress Financial initiated coverage with a Buy rating and set a $600.00 price target.
Brookfield Infrastructure Partners (BIP) — Canadian Imperial Bank of Commerce set a price target of $44.00.
Builders FirstSource (BLDR) — William Blair downgraded the stock from Outperform to Market Perform.
Burford Capital (BUR) — Wedbush reiterated its Neutral rating with a $3.65 price target.
Burlington Stores (BURL) — Wolfe Research initiated coverage with a Outperform rating and set a $356 price target.
Cameco (CCJ) — Truist Financial maintained its Buy rating and lowered its price target to $125.00 from $130.00.
Candel Therapeutics (CADL) — Jefferies Financial Group initiated coverage with a Buy rating and set a $25.00 price target.
Capital One Financial (COF) — UBS Group reiterated its Buy rating.
Carlyle Secured Lending (CGBD) — Raymond James Financial set a price target of $11.00.
CAVA Group (CAVA) — UBS Group reiterated its Buy rating.
Celcuity (CELC) — Cantor Fitzgerald initiated coverage with a Overweight rating and set a $140.00 price target.
Cencora (COR) — Robert W. Baird maintained its Outperform rating and raised its price target to $375.00 from $373.00.
CenterPoint Energy (CNP) — HSBC initiated coverage with a Buy rating and set a $44.00 price target.
CenterPoint Energy (CNP) — TD Cowen initiated coverage with a Buy rating and set a $47.00 price target.
Centrus Energy (LEU) — Barclays set a price target of $150.00.
Centrus Energy (LEU) — Truist Financial maintained its Buy rating and lowered its price target to $178.00 from $215.00.
Cheesecake Factory (CAKE) — Robert W. Baird maintained its Neutral rating and raised its price target to $120.00 from $105.00.
Chipotle Mexican Grill (CMG) — DA Davidson set a price target of $45.00.
Choice Hotels International (CHH) — Morgan Stanley set a price target of $93.00.
Chubb (CB) — Mizuho maintained its Neutral rating and raised its price target to $350.00 from $336.00.
Chubb (CB) — Wells Fargo & Company maintained its Equal Weight rating and raised its price target to $366.00 from $343.00.
Clean Harbors (CLH) — Robert W. Baird maintained its Outperform rating and raised its price target to $365.00 from $360.00.
Cleanspark (CLSK) — Canaccord Genuity Group initiated coverage with a Buy rating and set a $20.00 price target.
Cleveland-Cliffs (CLF) — Barclays maintained its Underweight rating and raised its price target to $12.00 from $11.00.
Cleveland-Cliffs (CLF) — B. Riley Financial maintained its Buy rating and raised its price target to $18.00 from $15.00.
Cleveland-Cliffs (CLF) — JPMorgan Chase & Co. maintained its Neutral rating and raised its price target to $13.00 from $12.00.
CME Group (CME) — Barclays maintained its Equal Weight rating and raised its price target to $321.00 from $281.00.
CME Group (CME) — CLSA set a price target of $367.00.
CME Group (CME) — JPMorgan upgraded the stock from Underweight to Overweight and set a $367 price target.
CME Group (CME) — Morgan Stanley set a price target with a price target of $359.00, revised from $337.00.
CME Group (CME) — Piper Sandler reiterated its Overweight rating with a price target of $330.00, revised from $295.00.
CME Group (CME) — Wells Fargo & Company maintained its Overweight rating and raised its price target to $333.00 from $315.00.
CMS Energy (CMS) — HSBC changed its rating from Underperform to Hold and set a $69.00 price target.
Community Trust Bancorp (CTBI) — Piper Sandler maintained its Neutral rating and lowered its price target to $75.00 from $81.00.
Consolidated Edison (ED) — HSBC initiated coverage with a Hold rating and set a $104.00 price target.
Constellation Energy (CEG) — HSBC initiated coverage with a Buy rating and set a $335 price target.
Crescent Capital BDC (CCAP) — Raymond James Financial set a price target of $10.00.
Crown Castle (CCI) — TD Cowen maintained its Buy rating and raised its price target to $98.00 from $92.00.
CSX (CSX) — Bank of America maintained its Buy rating and raised its price target to $57.00 from $55.00.
CSX (CSX) — JPMorgan Chase & Co. maintained its Overweight rating and raised its price target to $58.00 from $57.00.
CSX (CSX) — Royal Bank Of Canada reiterated its Outperform rating with a price target of $54.00, revised from $53.00.
CSX (CSX) — Sanford C. Bernstein reiterated its Market Perform rating with a $49.00 price target.
CSX (CSX) — TD Cowen reiterated its Buy rating with a price target of $55.00, revised from $54.00.
CSX (CSX) — UBS Group reiterated its Buy rating with a $60.00 price target.
Cushman & Wakefield (CWK) — Citigroup reiterated its existing rating with a $11.83 price target.
Cushman & Wakefield (CWK) — Citizens Jmp maintained its Market Outperform rating and lowered its price target to $16.00 from $19.00.
Cybin (HELP) — Wells Fargo & Company maintained its Overweight rating and raised its price target to $22.00 from $16.00.
Danaher (DHR) — Robert W. Baird maintained its Outperform rating and raised its price target to $254.00 from $246.00.
Danaher (DHR) — Barclays maintained its Overweight rating and raised its price target to $260.00 from $255.00.
Danaher (DHR) — Citigroup reiterated its Buy rating.
Danaher (DHR) — JPMorgan Chase & Co. maintained its Overweight rating and raised its price target to $270.00 from $250.00.
Danaher (DHR) — Stifel Nicolaus maintained its Buy rating and raised its price target to $260.00 from $220.00.
Danaher (DHR) — TD Cowen maintained its Buy rating and raised its price target to $270.00 from $255.00.
Danaher (DHR) — The Goldman Sachs Group reiterated its Buy rating with a $275.00 price target.
Danaher (DHR) — UBS Group reiterated its Buy rating with a $260.00 price target.
DarkHorse Technologies (DRK) — Maxim Group initiated coverage with a Buy rating and set a $6.00 price target.
Deckers Outdoor (DECK) — Wolfe Research initiated coverage with a Peer Perform rating.
Delek US (DK) — TD Cowen maintained its Buy rating and raised its price target to $90.00 from $85.00.
DENTSPLY SIRONA (XRAY) — Mizuho maintained its Neutral rating and lowered its price target to $12.00 from $14.00.
Dick’s Sporting Goods (DKS) — Wolfe Research initiated coverage with a Outperform rating and set a $181 price target.
Dime Community Bancshares (DCOM) — DA Davidson set a price target of $50.00.
DraftKings (DKNG) — Moffett Nathanson reiterated its Neutral rating with a $22.00 price target.
DTE Energy (DTE) — HSBC initiated coverage with a Hold rating and set a $135.00 price target.
Duke Energy (DUK) — HSBC initiated coverage with a Hold rating and set a $123.00 price target.
Dutch Bros (BROS) — RBC downgraded the stock from Outperform to Sector Perform with a price target of $46.00, revised from $70.00.
East West Bancorp (EWBC) — Citigroup reiterated its Buy rating.
Edison International (EIX) — HSBC initiated coverage with a Hold rating and set a $56.50 price target.
Electra Therapeutics (ETRA) — JPMorgan Chase & Co. initiated coverage with a Overweight rating and set a $36.00 price target.
Element Solutions (ESI) — Mizuho maintained its Neutral rating and raised its price target to $44.00 from $42.00.
Elevance Health (ELV) — Robert W. Baird maintained its Neutral rating and raised its price target to $406.00 from $393.00.
Elevance Health (ELV) — Barclays maintained its Overweight rating and raised its price target to $472.00 from $469.00.
Elevance Health (ELV) — Guggenheim set a price target of $485.00.
Elevance Health (ELV) — Royal Bank Of Canada maintained its Sector Perform rating and raised its price target to $455.00 from $424.00.
Elevance Health (ELV) — UBS Group set a price target of $523.00.
Enbridge (ENB) — Canadian Imperial Bank of Commerce reiterated its existing rating with a $47.94 price target.
Entergy (ETR) — HSBC initiated coverage with a Buy rating and set a $123.50 price target.
Equifax (EFX) — Argus upgraded the stock from Hold to Buy and set a $200 price target.
Essential Properties Realty Trust (EPRT) — Raymond James Financial reiterated its Strong-Buy rating with a $37.00 price target.
Essential Properties Realty Trust (EPRT) — Stifel Nicolaus maintained its Buy rating and lowered its price target to $32.50 from $36.00.
Evergy (EVRG) — HSBC initiated coverage with a Buy rating and set a $92.00 price target.
Evergy (EVRG) — TD Cowen initiated coverage with a Buy rating and set a $95.00 price target.
Eversource Energy (ES) — HSBC initiated coverage with a Hold rating and set a $70.00 price target.
Exelon (EXC) — HSBC initiated coverage with a Hold rating and set a $44.00 price target.
Extreme Networks (EXTR) — Rosenblatt Securities reiterated its Buy rating with a $38.00 price target.
Fifth Third Bancorp (FITB) — Citigroup reiterated its Buy rating.
First Bancorp (FBNC) — Piper Sandler maintained its Neutral rating and raised its price target to $66.00 from $65.00.
FirstEnergy (FE) — HSBC initiated coverage with a Buy rating and set a $50.00 price target.
FirstEnergy (FE) — Jefferies Financial Group reiterated its Hold rating.
Flutter Entertainment (FLUT) — Moffett Nathanson reiterated its Neutral rating with a $92.00 price target.
Galaxy Digital (GLXY) — Maxim Group set a price target of $36.00.
Gap (GAP) — Wolfe Research initiated coverage with a Peer Perform rating.
Genpact (G) — Susquehanna maintained its Neutral rating and raised its price target to $40.00 from $37.00.
Genuine Parts (GPC) — Argus maintained its Buy rating and lowered its price target to $150.00 from $156.00.
Geopark (GPRK) — Jefferies Financial Group reiterated its Buy rating with a $13.50 price target.
GSI Technology (GSIT) — Needham & Company LLC reiterated its Buy rating with a $9.00 price target.
Halliburton (HAL) — UBS Group set a price target of $41.00.
Heritage Financial (HFWA) — Raymond James Financial reiterated its Market Perform rating.
HF Sinclair (DINO) — TD Cowen maintained its Hold rating and raised its price target to $110.00 from $100.00.
indie Semiconductor (INDI) — B. Riley Financial maintained its Buy rating and lowered its price target with a $119.00 price target.
Integra LifeSciences (IART) — BMO Capital Markets reiterated its Market Perform rating with a price target of $14.00, revised from $15.00.
Integra LifeSciences (IART) — Citizens Jmp maintained its Market Outperform rating and lowered its price target to $22.00 from $25.00.
Integra LifeSciences (IART) — JPMorgan Chase & Co. maintained its Underweight rating and lowered its price target to $14.00 from $17.00.
Integra LifeSciences (IART) — Wells Fargo & Company set a price target with a price target of $13.00, revised from $15.00.
Intercontinental Hotels Group (IHG) — Bank of America reiterated its Buy rating.
International Business Machines (IBM) — Robert W. Baird maintained its Neutral rating and raised its price target to $260.00 from $230.00.
International Business Machines (IBM) — Barclays maintained its Overweight rating and raised its price target to $277.00 from $262.00.
International Business Machines (IBM) — BMO Capital Markets reiterated its Market Perform rating with a price target of $265.00, revised from $230.00.
International Business Machines (IBM) — Citigroup reiterated its Buy rating.
International Business Machines (IBM) — Jefferies Financial Group reiterated its Buy rating with a $280.00 price target.
International Business Machines (IBM) — JPMorgan Chase & Co. maintained its Overweight rating and raised its price target to $269.00 from $250.00.
International Business Machines (IBM) — Morgan Stanley set a price target with a price target of $240.00, revised from $238.00.
International Business Machines (IBM) — Royal Bank Of Canada reiterated its Outperform rating with a $270.00 price target.
International Business Machines (IBM) — Stifel Nicolaus maintained its Buy rating and raised its price target to $260.00 from $235.00.
International Business Machines (IBM) — The Goldman Sachs Group reiterated its Buy rating with a $300.00 price target.
International Business Machines (IBM) — Truist Financial set a price target of $260.00.
International Business Machines (IBM) — UBS Group set a price target of $243.00.
International Flavors & Fragrances (IFF) — Oppenheimer maintained its Outperform rating and raised its price target to $108.00 from $95.00.
Ionic Digital (IOND) — Canaccord Genuity initiated coverage with a Buy rating and set a $119 price target.
Ionis Pharmaceuticals (IONS) — BMO Capital Markets upgraded the stock from Market Perform to Outperform with a price target of $66.00, revised from $54.00.
Ionis Pharmaceuticals (IONS) — HC Wainwright reiterated its Buy rating.
JBS (JBS) — JPMorgan Chase & Co. maintained its Overweight rating and lowered its price target to $17.50 from $18.00.
Kardigan (KARD) — Robert W. Baird initiated coverage with a Outperform rating and set a $43 price target.
Karman (KRMN) — Oppenheimer initiated coverage with a Outperform rating and set a $40.00 price target.
Karman (KRMN) — UBS Group set a price target of $40.00.
Keurig Dr Pepper (KDP) — JPMorgan Chase & Co. maintained its Overweight rating and raised its price target to $39.00 from $38.00.
Kinder Morgan (KMI) — BMO Capital Markets reiterated its Outperform rating with a price target of $37.00, revised from $36.00.
Kinder Morgan (KMI) — Jefferies Financial Group reiterated its Hold rating.
Kinder Morgan (KMI) — Mizuho maintained its Outperform rating and raised its price target to $39.00 from $37.00.
Kinder Morgan (KMI) — Morgan Stanley set a price target of $39.00.
Kinder Morgan (KMI) — TD Cowen maintained its Buy rating and raised its price target to $40.00 from $38.00.
Kinder Morgan (KMI) — Wells Fargo & Company maintained its Overweight rating and raised its price target to $39.00 from $36.00.
Knight-Swift Transportation (KNX) — JPMorgan Chase & Co. maintained its Neutral rating and raised its price target to $74.00 from $68.00.
Knight-Swift Transportation (KNX) — Raymond James Financial reiterated its Strong-Buy rating with a $84.00 price target.
Knight-Swift Transportation (KNX) — Stifel Nicolaus maintained its Buy rating and raised its price target to $92.00 from $90.00.
Knight-Swift Transportation (KNX) — UBS Group reiterated its Buy rating.
Knight-Swift Transportation (KNX) — Wells Fargo & Company maintained its Overweight rating and lowered its price target to $79.00 from $81.00.
Kodiak AI (KDK) — Chardan Capital maintained its Buy rating and lowered its price target with a $4.50 price target.
Kohl’s (KSS) — Gordon Haskett upgraded the stock from Hold to Buy and set a $27 price target.
Kratos Defense & Security Solutions (KTOS) — Oppenheimer initiated coverage with a Outperform rating and set a $50.00 price target.
Kyverna Therapeutics (KYTX) — HC Wainwright reiterated its Buy rating.
Lam Research (LRCX) — Bank of America reiterated its Buy rating with a $345.00 price target.
Lam Research (LRCX) — Citigroup reiterated its Buy rating.
Lam Research (LRCX) — Mizuho maintained its Outperform rating and lowered its price target to $360.00 from $365.00.
Lam Research (LRCX) — Morgan Stanley set a price target of $339.00.
Lam Research (LRCX) — Needham & Company LLC maintained its Buy rating and lowered its price target to $290.00 from $390.00.
Lam Research (LRCX) — UBS Group reiterated its Buy rating with a $400.00 price target.
Las Vegas Sands (LVS) — Bank of America maintained its Neutral rating and lowered its price target to $45.00 from $50.00.
Las Vegas Sands (LVS) — Barclays maintained its Overweight rating and lowered its price target to $50.00 from $57.00.
Las Vegas Sands (LVS) — Mizuho maintained its Outperform rating and lowered its price target to $54.00 from $61.00.
Las Vegas Sands (LVS) — Morgan Stanley set a price target with a price target of $49.00, revised from $55.00.
Las Vegas Sands (LVS) — Stifel Nicolaus maintained its Buy rating and lowered its price target to $52.00 from $54.00.
Las Vegas Sands (LVS) — The Goldman Sachs Group set a price target of $41.00.
Las Vegas Sands (LVS) — Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to $40.00 from $44.00.
Leonardo DRS (DRS) — Oppenheimer initiated coverage with a Outperform rating and set a $45.00 price target.
Lithia Motors (LAD) — JPMorgan Chase & Co. maintained its Neutral rating and lowered its price target to $315.00 from $320.00.
lululemon athletica (LULU) — Wolfe Research initiated coverage with a Underperform rating and set a $75.00 price target.
Marathon Petroleum (MPC) — TD Cowen maintained its Buy rating and raised its price target to $478.00 from $450.00.
Marriott Vacations Worldwide (VAC) — Morgan Stanley set a price target of $63.00.
MasTec (MTZ) — The Goldman Sachs Group reiterated its Buy rating with a $274.00 price target.
Medline (MDLN) — Mizuho maintained its Outperform rating and lowered its price target to $45.00 from $48.00.
Mercury Systems (MRCY) — Oppenheimer initiated coverage with a Outperform rating and set a $90.00 price target.
Meta Platforms (META) — Bank of America maintained its Buy rating and raised its price target to $845.00 from $810.00.
Meta Platforms (META) — Barclays maintained its Overweight rating and raised its price target to $880.00 from $780.00.
Meta Platforms (META) — BMO Capital Markets reiterated its Market Perform rating with a price target of $685.00, revised from $580.00.
Meta Platforms (META) — Cantor Fitzgerald maintained its Overweight rating and raised its price target to $860.00 from $840.00.
Meta Platforms (META) — Citizens Jmp reiterated its Market Outperform rating with a $885.00 price target.
Meta Platforms (META) — Evercore reiterated its existing rating with a $644.56 price target.
Meta Platforms (META) — Guggenheim reiterated its Buy rating with a $850.00 price target.
Meta Platforms (META) — JPMorgan Chase & Co. maintained its Overweight rating and raised its price target to $940.00 from $920.00.
Meta Platforms (META) — KeyCorp maintained its Overweight rating and raised its price target to $905.00 from $900.00.
Meta Platforms (META) — Mizuho maintained its Outperform rating and raised its price target to $950.00 from $750.00.
Meta Platforms (META) — Monness Crespi & Hardt reiterated its Buy rating with a $875.00 price target.
Meta Platforms (META) — Piper Sandler maintained its Overweight rating and lowered its price target to $850.00 from $875.00.
Meta Platforms (META) — Pivotal Research maintained its Buy rating and raised its price target to $960.00 from $930.00.
Meta Platforms (META) — Royal Bank Of Canada maintained its Outperform rating and raised its price target to $800.00 from $770.00.
Meta Platforms (META) — Scotiabank maintained its Sector Perform rating and raised its price target to $650.00 from $600.00.
Meta Platforms (META) — Susquehanna maintained its Positive rating and raised its price target to $850.00 from $650.00.
Meta Platforms (META) — TD Cowen maintained its Buy rating and lowered its price target to $850.00 from $865.00.
Meta Platforms (META) — The Goldman Sachs Group reiterated its Buy rating with a $885.00 price target.
Meta Platforms (META) — UBS Group reiterated its Outperform rating with a $920.00 price target.
Meta Platforms (META) — Wedbush maintained its Neutral rating and raised its price target to $730.00 from $700.00.
Meta Platforms (META) — Wells Fargo & Company maintained its Overweight rating and lowered its price target to $995.00 from $1,000.00.
Microchip Technology (MCHP) — B. Riley Financial maintained its Buy rating and lowered its price target to $98.00 from $108.00.
Micron Technology (MU) — Needham & Company LLC reiterated its Buy rating with a $1,650.00 price target.
Micron Technology (MU) — Rosenblatt Securities reiterated its Buy rating with a $1,900.00 price target.
MidCap Financial Investment (MFIC) — Raymond James Financial set a price target of $9.50.
Monster Beverage (MNST) — Citigroup reiterated its Buy rating.
Monster Beverage (MNST) — Stifel Nicolaus set a price target of $52.00.
Moody’s (MCO) — Bank of America maintained its Buy rating and lowered its price target to $575.00 from $580.00.
Moody’s (MCO) — BMO Capital Markets reiterated its Market Perform rating with a price target of $511.00, revised from $490.00.
Moody’s (MCO) — Morgan Stanley set a price target of $480.00.
Moody’s (MCO) — Stifel Nicolaus maintained its Buy rating and lowered its price target to $537.00 from $550.00.
Moody’s (MCO) — Wells Fargo & Company maintained its Overweight rating and lowered its price target to $595.00 from $597.00.
Morgan Stanley Direct Lending Fund (MSDL) — Raymond James Financial set a price target of $15.00.
Murphy USA (MUSA) — JPMorgan Chase & Co. maintained its Overweight rating and lowered its price target to $626.00 from $633.00.
MYR Group (MYRG) — The Goldman Sachs Group reiterated its Neutral rating with a $331.00 price target.
Nano Nuclear Energy (NNE) — Truist Financial maintained its Hold rating and lowered its price target to $19.00 from $22.00.
Nasdaq (NDAQ) — Jefferies Financial Group reiterated its Hold rating.
Neptune Insurance (NP) — Morgan Stanley set a price target of $35.00.
Netflix (NFLX) — Argus set a price target with a price target of $95.00, revised from $120.00.
Netflix (NFLX) — Wolfe Research downgraded the stock from Outperform to Peer Perform.
NETSTREIT (NTST) — Stifel Nicolaus maintained its Buy rating and lowered its price target to $21.25 from $23.50.
Newell Brands (NWL) — UBS Group reiterated its Neutral rating.
Newmark Group (NMRK) — Citigroup reiterated its existing rating with a $11.78 price target.
Newmark Group (NMRK) — Citizens Jmp maintained its Market Outperform rating and lowered its price target to $17.00 from $22.00.
NextEra Energy (NEE) — BTIG Research set a price target of $106.00.
NextEra Energy (NEE) — HSBC set a price target of $103.00.
NIKE (NKE) — Barclays reiterated its Overweight rating with a price target of $45.00, revised from $37.00.
NIKE (NKE) — BTIG Research reiterated its Buy rating with a $50.00 price target.
NIKE (NKE) — UBS Group reiterated its Neutral rating.
Nike (NKE) — Wolfe Research initiated coverage with a Underperform rating and set a $28 price target.
NiSource (NI) — HSBC initiated coverage with a Buy rating and set a $49.50 price target.
Northern Trust (NTRS) — Barclays maintained its Equal Weight rating and raised its price target to $194.00 from $189.00.
Northern Trust (NTRS) — Morgan Stanley reiterated its Underweight rating with a $177.00 price target.
Northpointe Bancshares (NPB) — Piper Sandler maintained its Overweight rating and lowered its price target to $19.50 from $20.00.
Northrop Grumman (NOC) — Barclays maintained its Underweight rating and raised its price target to $430.00 from $419.00.
Northwest Natural Gas (NWN) — Mizuho initiated coverage with a Neutral rating and set a $51.00 price target.
Northwest Natural Gas (NWN) — Morgan Stanley downgraded the stock to Buy.
NRG Energy (NRG) — HSBC initiated coverage with a Buy rating and set a $179.00 price target.
NuScale Power (SMR) — Truist Financial maintained its Hold rating and lowered its price target to $8.00 from $10.00.
Nutrien (NTR) — Oppenheimer maintained its Outperform rating and lowered its price target to $78.00 from $80.00.
Oklo (OKLO) — Truist Financial maintained its Hold rating and lowered its price target to $31.00 from $51.00.
Old National Bancorp (ONB) — JPMorgan Chase & Co. maintained its Overweight rating and lowered its price target to $29.00 from $30.00.
Old National Bancorp (ONB) — TD Cowen maintained its Buy rating and lowered its price target to $29.00 from $30.00.
Omega Healthcare Investors (OHI) — Citigroup upgraded the stock from Buy to Outperform.
Omega Healthcare Investors (OHI) — Citizens upgraded the stock from Market Perform to Market Outperform and set a $52 price target.
On Holding (ONON) — Wolfe Research initiated coverage with a Outperform rating and set a $47 price target.
onsemi (ON) — B. Riley Financial maintained its Buy rating and lowered its price target to $105.00 from $127.00.
Opus Genetics (IRD) — Chardan Capital reiterated its Buy rating with a price target of $9.00, revised from $16.00.
Oracle (ORCL) — Cantor Fitzgerald reiterated its Overweight rating with a $284.00 price target.
Pacific Gas & Electric (PCG) — HSBC initiated coverage with a Buy rating and set a $15.50 price target.
Palantir Technologies (PLTR) — Citigroup reiterated its Buy rating.
Parabilis Medicines (PBLS) — HC Wainwright initiated coverage with a Buy rating and set a $40.00 price target.
PBF Energy (PBF) — TD Cowen maintained its Hold rating and raised its price target to $75.00 from $73.00.
Pebblebrook Hotel Trust (PEB) — Morgan Stanley set a price target of $15.00.
Pegasystems (PEGA) — Barclays set a price target with a price target of $42.00, revised from $43.00.
Pegasystems (PEGA) — DA Davidson set a price target of $35.00.
Pegasystems (PEGA) — Royal Bank Of Canada reiterated its Outperform rating with a price target of $40.00, revised from $35.00.
Pembina Pipeline (PBA) — Canadian Imperial Bank of Commerce downgraded the stock from Outperform to Neutral.
Peoples Bancorp (PEBO) — Piper Sandler maintained its Overweight rating and raised its price target to $48.00 from $46.00.
Philip Morris International (PM) — Needham & Company LLC maintained its Buy rating and raised its price target to $220.00 from $215.00.
Philip Morris International (PM) — UBS Group reiterated its Neutral rating with a $201.00 price target.
Phillips 66 (PSX) — TD Cowen maintained its Buy rating and raised its price target to $308.00 from $295.00.
Pinnacle West Capital (PNW) — HSBC initiated coverage with a Buy rating and set a $119.50 price target.
PPL (PPL) — Bank of America reiterated its Buy rating.
PPL (PPL) — HSBC initiated coverage with a Buy rating and set a $42.00 price target.
Prudential Financial (PRU) — JPMorgan Chase & Co. maintained its Neutral rating and lowered its price target to $124.00 from $127.00.
Public Service Enterprise Group (PEG) — HSBC initiated coverage with a Hold rating and set a $72.50 price target.
Qiagen (QGEN) — Robert W. Baird maintained its Outperform rating and raised its price target to $52.00 from $50.00.
Qiagen (QGEN) — JPMorgan Chase & Co. changed its rating from Overweight to Neutral with a price target of $52.00, revised from $55.00.
Quanta Services (PWR) — The Goldman Sachs Group set a price target of $781.00.
Quantinuum (QNT) — Rosenblatt Securities reiterated its Buy rating with a $155.00 price target.
QuantumScape (QS) — Robert W. Baird maintained its Neutral rating and lowered its price target to $6.00 from $8.00.
Rani Therapeutics (RANI) — Chardan Capital reiterated its Buy rating.
RBB Bancorp (RBB) — Stephens reiterated its Positive rating.
Reliance (RS) — Wells Fargo & Company maintained its Equal Weight rating and raised its price target to $420.00 from $391.00.
Republic Services (RSG) — Robert W. Baird maintained its Neutral rating and raised its price target to $245.00 from $242.00.
Riley Exploration Permian (REPX) — Roth Capital reiterated its Buy rating.
Rithm Capital (RITM) — Wedbush reiterated its Outperform rating with a $10.00 price target.
Rithm Property Trust (RPT) — Wedbush reiterated its Outperform rating with a $13.50 price target.
Rogers (ROG) — B. Riley Financial maintained its Buy rating and lowered its price target to $195.00 from $225.00.
Ross Stores (ROST) — Wolfe Research initiated coverage with a Outperform rating and set a $279 price target.
SAP (SAP) — BMO Capital Markets maintained its Outperform rating and raised its price target to $265.00 from $235.00.
SAP (SAP) — Jefferies Financial Group reiterated its Buy rating.
SEI Investments (SEIC) — Morgan Stanley reiterated its Overweight rating with a $127.00 price target.
SEI Investments (SEIC) — Piper Sandler reiterated its Overweight rating with a price target of $129.00, revised from $127.00.
Sempra Energy (SRE) — HSBC initiated coverage with a Buy rating and set a $97.50 price target.
SentinelOne (S) — DA Davidson set a price target of $20.00.
SentinelOne (S) — Jefferies Financial Group reiterated its Buy rating.
SentinelOne (S) — Susquehanna reiterated its Positive rating.
SentinelOne (S) — Wedbush maintained its Outperform rating and raised its price target to $27.00 from $25.00.
Shake Shack (SHAK) — UBS Group reiterated its Neutral rating with a $73.00 price target.
Six Flags Entertainment (FUN) — Citizens Jmp maintained its Market Outperform rating and lowered its price target to $14.00 from $24.00.
Sky Harbour Group (SKYH) — BTIG Research reiterated its Buy rating with a $13.00 price target.
Soluna (SLNH) — Rosenblatt Securities maintained its Buy rating and lowered its price target with a $2.00 price target.
South Bow (SOBO) — Canadian Imperial Bank of Commerce reiterated its Neutral rating with a $35.00 price target.
Southern (SO) — HSBC initiated coverage with a Buy rating and set a $99.50 price target.
SpaceX (SPCX) — Bank of America maintained its Buy rating and raised its price target to $275.00 from $235.00.
Stifel Financial (SF) — Citigroup reiterated its existing rating with a $67.36 price target.
Stifel Financial (SF) — JPMorgan Chase & Co. maintained its Neutral rating and lowered its price target to $80.00 from $82.00.
Stifel Financial (SF) — UBS Group set a price target of $83.00.
Symbotic (SYM) — TD Cowen maintained its Buy rating and lowered its price target to $70.00 from $75.00.
Talen Energy (TLN) — HSBC initiated coverage with a Buy rating and set a $444.30 price target.
Talen Energy (TLN) — TD Cowen initiated coverage with a Buy rating and set a $475.00 price target.
TC Energy (TRP) — Canadian Imperial Bank of Commerce set a price target of $99.00.
Teledyne Technologies (TDY) — Stifel Nicolaus maintained its Buy rating and raised its price target to $795.00 from $775.00.
Tesla (TSLA) — BNP Paribas Exane upgraded the stock from Underperform to Neutral.
Tesla (TSLA) — Canaccord Genuity Group set a price target of $442.00.
Tesla (TSLA) — CLSA upgraded the stock from Underperform to Hold and set a $400 price target.
Tesla (TSLA) — Glj Research reiterated its Sell rating.
Tesla (TSLA) — JPMorgan Chase & Co. maintained its Neutral rating and raised its price target to $430.00 from $415.00.
Tesla (TSLA) — Mizuho maintained its Outperform rating and raised its price target to $460.00 from $450.00.
Tesla (TSLA) — Morgan Stanley maintained its Equal Weight rating and raised its price target to $410.00 from $400.00.
Tesla (TSLA) — Needham & Company LLC reiterated its Hold rating.
Tesla (TSLA) — Oppenheimer changed its rating from Market Perform to Outperform.
Tesla (TSLA) — Piper Sandler reiterated its Overweight rating with a price target of $475.00, revised from $450.00.
Tesla (TSLA) — Royal Bank Of Canada reiterated its Outperform rating with a $480.00 price target.
Tesla (TSLA) — Stifel Nicolaus set a price target of $475.00.
Tesla (TSLA) — TD Cowen reiterated its Buy rating with a $460.00 price target.
Tesla (TSLA) — The Goldman Sachs Group reiterated its Neutral rating.
Tesla (TSLA) — Tigress Financial initiated coverage with a Buy rating.
Tesla (TSLA) — UBS Group reiterated its Neutral rating with a $425.00 price target.
Texas Capital Bancshares (TCBI) — DA Davidson set a price target of $105.00.
Texas Capital Bancshares (TCBI) — Piper Sandler maintained its Neutral rating and raised its price target to $101.00 from $100.00.
Texas Capital Bancshares (TCBI) — Royal Bank Of Canada maintained its Sector Perform rating and lowered its price target to $110.00 from $113.00.
Texas Instruments (TXN) — Barclays maintained its Equal Weight rating and raised its price target to $280.00 from $250.00.
Texas Instruments (TXN) — Citigroup reiterated its Buy rating.
Texas Instruments (TXN) — Jefferies Financial Group reiterated its Hold rating with a $300.00 price target.
Texas Instruments (TXN) — JPMorgan Chase & Co. maintained its Overweight rating and raised its price target to $365.00 from $340.00.
Texas Instruments (TXN) — Mizuho maintained its Neutral rating and lowered its price target to $290.00 from $305.00.
Texas Instruments (TXN) — Morgan Stanley reiterated its Underweight rating with a $278.00 price target.
Texas Instruments (TXN) — Rosenblatt Securities maintained its Buy rating and raised its price target to $360.00 from $350.00.
Texas Instruments (TXN) — Stifel Nicolaus maintained its Buy rating and raised its price target to $370.00 from $360.00.
Texas Instruments (TXN) — Susquehanna reiterated its Positive rating.
Texas Instruments (TXN) — The Goldman Sachs Group reiterated its Sell rating with a $250.00 price target.
Texas Instruments (TXN) — Truist Financial set a price target of $305.00.
Texas Instruments (TXN) — UBS Group reiterated its Buy rating.
Thermo Fisher Scientific (TMO) — Robert W. Baird maintained its Outperform rating and raised its price target to $756.00 from $723.00.
Thermo Fisher Scientific (TMO) — Barclays maintained its Overweight rating and raised its price target to $775.00 from $750.00.
Thermo Fisher Scientific (TMO) — Royal Bank Of Canada maintained its Sector Perform rating and raised its price target to $730.00 from $580.00.
Thermo Fisher Scientific (TMO) — Stifel Nicolaus maintained its Buy rating and raised its price target to $775.00 from $650.00.
Thermo Fisher Scientific (TMO) — TD Cowen maintained its Buy rating and raised its price target to $810.00 from $760.00.
Thermo Fisher Scientific (TMO) — UBS Group reiterated its Buy rating with a $800.00 price target.
TJX Companies (TJX) — Wolfe Research initiated coverage with a Peer Perform rating.
Travel + Leisure (TNL) — Morgan Stanley reiterated its Overweight rating with a $86.00 price target.
Ultrapar Participacoes (UGP) — JPMorgan downgraded the stock from Overweight to Neutral.
United Airlines (UAL) — Argus maintained its Buy rating and lowered its price target to $125.00 from $140.00.
United Airlines (UAL) — BMO Capital Markets reiterated its Outperform rating with a price target of $135.00, revised from $140.00.
United Airlines (UAL) — Susquehanna maintained its Positive rating and lowered its price target to $130.00 from $150.00.
United Airlines (UAL) — Wells Fargo & Company maintained its Overweight rating and lowered its price target to $155.00 from $160.00.
United Rentals (URI) — Bank of America reiterated its Buy rating.
United Rentals (URI) — UBS Group reiterated its Buy rating with a $1,450.00 price target.
United Therapeutics (UTHR) — Royal Bank Of Canada maintained its Outperform rating and lowered its price target to $697.00 from $708.00.
UnitedHealth Group (UNH) — Mizuho maintained its Outperform rating and raised its price target to $500.00 from $493.00.
Urban Outfitters (URBN) — Wolfe Research initiated coverage with a Peer Perform rating.
Valero Energy (VLO) — TD Cowen maintained its Hold rating and raised its price target to $400.00 from $375.00.
Veradermics (MANE) — B. Riley Financial maintained its Buy rating and raised its price target to $204.00 from $170.00.
Veradermics (MANE) — UBS Group set a price target of $204.00.
Viking (VIK) — Morgan Stanley set a price target of $94.00.
Vistra (VST) — HSBC initiated coverage with a Buy rating and set a $190.00 price target.
Vita Coco (COCO) — William Blair reiterated its Market Perform rating.
Weatherford International (WFRD) — Barclays maintained its Overweight rating and lowered its price target to $139.00 from $148.00.
Weatherford International (WFRD) — Royal Bank Of Canada maintained its Outperform rating and lowered its price target to $123.00 from $124.00.
WEC Energy Group (WEC) — HSBC initiated coverage with a Hold rating and set a $106.50 price target.
WeRide (WRD) — Barclays initiated coverage with a Equal Weight rating and set a $4.00 price target.
Western Alliance Bancorporation (WAL) — Stephens reiterated its existing rating with a $76.71 price target.
WhiteHorse Finance (WHF) — Raymond James upgraded the stock from Market Perform to Outperform and set a $9 price target.
Wingstop (WING) — Robert W. Baird maintained its Outperform rating and lowered its price target to $150.00 from $160.00.
Wingstop (WING) — DA Davidson set a price target of $180.00.
Winnebago Industries (WGO) — BMO Capital Markets maintained its Outperform rating and lowered its price target to $33.00 from $38.00.
Wyndham Hotels & Resorts (WH) — Morgan Stanley set a price target of $97.00.
Wyndham Hotels & Resorts (WH) — Stifel Nicolaus maintained its Buy rating and raised its price target to $99.00 from $98.00.
Xcel Energy (XEL) — HSBC initiated coverage with a Buy rating and set a $89.00 price target.
XTI Aerospace (XTIA) — Maxim Group set a price target of $2.00.
Zimmer Biomet (ZBH) — Argus reiterated its Buy rating with a $125.00 price target.
Zoom Communications (ZM) — Needham & Company LLC reiterated its Buy rating with a $130.00 price target.
STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.
Related research
US Analyst Updates: October 21st, 2026
US Analyst Updates — October 20th, 2026
US Analyst Updates: October 19th, 2026
A monthly perspective in your inbox.
Five research sections in the STA Research Professional Newsletter.